Androgen receptor genomic alterations and treatment resistance in metastatic prostate cancer.
Edmond M KwanAlexander W WyattPublished in: The Prostate (2022)
As treatment access and liquid biopsy technology continues to improve, we posit that real-time measures of AR biology are likely to play a key role in emerging precision oncology strategies for metastatic prostate cancer.